InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Thursday, 08/08/2019 8:50:27 AM

Thursday, August 08, 2019 8:50:27 AM

Post# of 1742
News: $EVOK Evoke Pharma to Resubmit Gimoti(TM) NDA Based on FDA Meeting Minutes and Announces Second Quarter 2019 Financial Results

SOLANA BEACH, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that following receipt of U.S. Food and Drug Administration (FDA) minutes from a type A mee...

Got this from Evoke Pharma to Resubmit Gimoti(TM) NDA Based on FDA Meeting Minutes and Announces Second Quarter 2019 Financial Results
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVOK News